China National Accord Medicines Corp Ltd logo

China National Accord Medicines Corp Ltd

SZSE:000028 (China)  
1
¥ 59.41 (+1.04%) May 29
P/E:
15.92
P/B:
1.54
Market Cap:
¥ 23.19B ($ 3.28B)
Enterprise V:
¥ 22.69B ($ 3.21B)
Volume:
3.19M
Avg Vol (2M):
5.54M
Volume:
3.19M
Market Cap ¥:
23.19B
Market Cap $:
3.28B
PE Ratio:
15.92
Avg Vol (2M):
5.54M
Enterprise Value ¥:
22.69B
Enterprise Value $:
3.21B
PB Ratio:
1.54
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for China National Accord Medicines Corp Ltd ( ) from 1993 to May 29 2023. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China National Accord Medicines stock (SZSE:000028) PE ratio as of May 29 2023 is 15.92. More Details

China National Accord Medicines Corp Ltd (SZSE:000028) PE Ratio (TTM) Chart

To

China National Accord Medicines Corp Ltd (SZSE:000028) PE Ratio (TTM) Historical Data

Total 1194
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
China National Accord Medicines PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2023-05-29 16.1 2023-03-21 13.2
2023-05-26 15.8 2023-03-20 13.4
2023-05-25 15.1 2023-03-17 14.1
2023-05-24 15.2 2023-03-16 13.4
2023-05-23 15.2 2023-03-15 12.2
2023-05-22 15.8 2023-03-14 12.1
2023-05-19 16.1 2023-03-13 12.0
2023-05-18 16.0 2023-03-10 11.9
2023-05-17 15.6 2023-03-09 12.4
2023-05-16 15.2 2023-03-08 12.5
2023-05-15 15.2 2023-03-07 11.9
2023-05-12 15.0 2023-03-06 11.6
2023-05-11 14.9 2023-03-03 11.1
2023-05-10 15.7 2023-03-02 10.9
2023-05-09 15.7 2023-03-01 10.9
2023-05-08 16.3 2023-02-28 10.9
2023-05-05 16.5 2023-02-27 10.6
2023-05-04 17.2 2023-02-24 10.7
2023-04-28 17.4 2023-02-23 10.7
2023-04-27 17.4 2023-02-22 10.7
2023-04-26 15.9 2023-02-21 10.7
2023-04-25 16.1 2023-02-20 10.6
2023-04-24 15.5 2023-02-17 10.6
2023-04-21 14.5 2023-02-16 10.5
2023-04-20 15.2 2023-02-15 10.3
2023-04-19 14.5 2023-02-14 10.2
2023-04-18 14.3 2023-02-13 9.9
2023-04-17 14.7 2023-02-10 9.8
2023-04-14 13.4 2023-02-09 9.9
2023-04-13 13.3 2023-02-08 9.8
2023-04-12 12.8 2023-02-07 10.0
2023-04-11 13.1 2023-02-06 9.9
2023-04-10 12.5 2023-02-03 10.0
2023-04-07 12.5 2023-02-02 10.2
2023-04-06 12.5 2023-02-01 10.1
2023-04-04 12.6 2023-01-31 10.1
2023-04-03 11.9 2023-01-30 10.1
2023-03-31 11.8 2023-01-20 10.3
2023-03-30 11.7 2023-01-19 10.3
2023-03-29 11.9 2023-01-18 10.1
2023-03-28 11.9 2023-01-17 10.1
2023-03-27 12.6 2023-01-16 10.1
2023-03-24 12.8 2023-01-13 10.2
2023-03-23 13.1 2023-01-12 10.2
2023-03-22 13.1 2023-01-11 10.1

China National Accord Medicines Corp Ltd (SZSE:000028) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.